Score breakdown
Strengths & weaknesses
- Historical: most-recommended vendor on r/Peptides through 2024 and into 2025
- Historical: broad catalog including the GLP-1 mainstream
- Historical: published Janoshik COAs on most batches
- Permanently offline since March 6, 2026
- 37 retatrutide samples failed Janoshik purity claims between Dec 2024 and Mar 2026
- At least one batch was flagged by Janoshik as a counterfeit (mass-spec identity mismatch)
- Federal pressure followed the quality collapse
What we tested
4 SKUS ORDEREDShipping & payment
MEDIAN ACROSS TEST ORDERSAudit notes
FROM THE BENCHWhat happened
Peptide Sciences ceased operations on March 6, 2026 after a slow-motion quality collapse that played out in public via Janoshik's third-party testing database. The vendor was, until late 2024, the most-recommended research-peptide source on r/Peptides — a status earned over years of broad catalog, consistent COA practices, and competitive pricing.
That position is what made the 2025 trajectory damaging: the community trusted Peptide Sciences enough to keep buying through declining quality signals, and the data trail Janoshik built over fifteen months is now the clearest documented case of a major vendor's quality erosion preceding shutdown.
The Janoshik trail
Across December 2024 and March 2026, Janoshik recorded 37 retatrutide samples submitted under Peptide Sciences batches that failed their labelled purity claims. The failure pattern was not random:
- Early 2025: results ran 2–4 percentage points below claimed purity. Within typical cross-lab tolerance; not a five-alarm signal individually.
- Mid 2025: failures clustered into specific lot ranges. Multiple buyers posting Janoshik QRs on r/Peptides reported under-spec results from the same batch IDs.
- Late 2025: at least one batch returned a mass-spec identity result inconsistent with retatrutide — Janoshik's terminology for an identity mismatch, the practical definition of a counterfeit.
The cumulative trend was visible to any reader of the Janoshik public-tests database. Several r/Peptides moderators surfaced the pattern in mid-2025 threads, but Peptide Sciences' brand inertia kept purchase volume high.
Federal pressure
The formal trigger for the March 2026 closure was federal pressure documented in PeptideLaws.com's FDA timeline and The Peptide Catalog's reporting. Both sources cite mounting regulator attention that paralleled the quality collapse. The specific enforcement action that ended operations has not been published in full — Peptide Sciences shut down rather than respond publicly.
This is structurally similar to the Amino Asylum (June 2025) and Paradigm Peptides (December 2025) closures: federal action arrives after public quality signals are already widespread, and the vendor's exit is faster than the regulatory record.
Lessons for buyers
Three operational rules emerge from the Peptide Sciences case, all visible from public data alone:
- Trend, not single failures. A vendor with one failed COA result is statistical noise. A vendor with five failures across three months on a flagship SKU is a leading indicator.
- Identity confirmation, not just purity. HPLC purity numbers can look acceptable on a counterfeit molecule. Janoshik's mass-spec identity tests are the gating signal — vendors whose COAs only include HPLC are concealing the dimension that matters most for novel compounds like retatrutide.
- Brand inertia is a buyer's risk. Peptide Sciences' community reputation kept buyers loyal months after the data turned. The instinct "I've ordered from them before, they're fine" is precisely the bias the audit framework exists to override.
Where the catalog migrated
The displaced reader population in early 2026 has primarily moved to:
- Limitless Biotech (formerly Limitless Life Nootropics) — current preview profile on this site
- Particle Peptides — current preview profile on this site
- Ascension Peptides — newer entrant filling the GLP-1 segment; current preview profile
Each has a current audit page with the relevant auditTier: public-data
flag while we ramp first-hand testing through the M1 cycle.
Related
- Three vendors closed in 12 months - the full pre-closure pattern, including Peptide Sciences' COA quality collapse
- Is Janoshik testing legit? - context on the COA-trend signal that preceded the closure
- How to verify a Janoshik COA
Sources
5 REFERENCES- Janoshik public-tests database — Janoshik Analytical
- Why Peptide Sciences shut down (March 2026) — The Peptide Catalog
- Peptide Sciences shutdown timeline + FDA pressure — PeptideLaws
- Every peptide vendor that shut down 2025-2026 — The Peptide Catalog
- Retatrutide identity fraud analysis — Kilo Biotechnology